معرفی
Joshua Morrow serves as a Research Fellow at Monash University within the Drug Delivery Disposition & Dynamics research group. His work focuses on advanced polymer-based drug delivery systems, particularly utilizing poly(2-oxazoline) and poly(2-oxazine) platforms for targeted therapeutic applications in nanomedicine and pharmaceutical sciences.
His research centers on designing water-soluble polymers for enhanced drug stability and delivery efficiency. Key investigations include blood-brain barrier penetration mechanisms for brain cancer therapy, chirality effects on nanoparticle-protein interactions, and development of novel lipid alternatives for mRNA delivery. Morrow's work bridges polymer chemistry with biomedical applications to address critical challenges in drug formulation and delivery.
Analysis of his 2024 publications reveals concentrated innovation in poly(2-oxazoline) derivatives, with significant contributions to hydrophilicity characterization, blood-brain barrier crossing enhancement, protein corona modulation, antiferroptosis drug conjugates, and mRNA-lipid nanoparticle stabilization. These studies demonstrate systematic advancement in biomaterial design for next-generation therapeutics.
No scientific awards were mentioned in the provided information.
Details regarding student advising and research grant funding were not specified in the available materials.
Morrow operates within Monash University's Drug Delivery Disposition & Dynamics group, maintaining extensive collaboration with the Kempe research team and international partners across polymer synthesis, nanomedicine development, and therapeutic application testing.
